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Abstract 
Rationale: Several studies have demonstrated links between infectious 
diseases and cardiovascular conditions. Malaria and hypertension are 
widespread in many low and middle-income countries but the possible link 
between them has not been considered. 
Objective: In this article we outline the basis for a possible link between 
malaria and hypertension, and discuss how the hypothesis could be 
confirmed or refuted. 
Methods and Results: We reviewed published literature on factors 
associated with hypertension and checked whether any of these were also 
associated with malaria. We then considered various study designs that could 
be used to test the hypothesis. Malaria causes low birth weight, malnutrition 
and inflammation, all of which are associated with hypertension in high-
income countries. The hypothetical link between malaria and hypertension 
can be tested through the use of ecological, cohort or Mendelian 
randomization studies, each of which poses specific challenges.  
Conclusions: Confirmation of the existence of a causative link with malaria 
would be a paradigm shift in efforts to prevent and control hypertension and 
would stimulate wider research on the links between infectious and non-
communicable disease. 
Keywords: Blood pressure; Arterial stiffness; Inflammation; sub-Saharan 
Africa; Malaria
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Nonstandard abbreviations and acronyms 
Ang-2: Angiopoietin-2 
BP: Blood pressure  
HIV: Human Immunodeficiency Virus 
LBW: Low birth weight 
LMIC: Low and middle-income countries 
MR: Mendelian Randomization 
SCT: Sickle cell trait 
 sSA: sub-Saharan Africa 
Introduction 
Age standardized mean blood pressures (BP) are higher in many parts of 
Asia and sub-Saharan Africa (sSA) than in high-income countries.1 Despite 
the high burden of cardiovascular disease in low and middle-income countries 
(LMIC), few studies have examined their aetiology, pathophysiology or 
treatment.2, 3 While demographic and lifestyle changes including urbanization4 
contribute substantially to the burden of hypertension in LMICs, examining 
factors unique to or more prevalent in LMIC settings might reveal new 
pathophysiological mechanisms that could aid efforts to control the condition. 
The rise of cardiovascular disease in LMIC is occurring against the 
background of continuing high burden of infectious diseases.5, 6 Several 
studies in more developed settings have reported links between infectious or 
inflammatory conditions and cardiovascular disease. In this article we outline 
the hypothesis that hypertension, the leading risk factor for death in LMIC 7, 
could be linked to one of the leading infectious conditions in the same region, 
malaria.  
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The malaria hypertension hypothesis 
We postulate that malaria contributes to the burden of hypertension in LMIC 
in the following ways (figure): 
(1) Malaria in pregnancy leads to low birth weight (LBW) through 
pathophysiologically connected mechanisms.8 In areas with high malaria 
endemicity where women are likely to have acquired immunity to prevent 
most febrile episodes, LBW results from fetal growth restriction which is a 
consequence of impaired uteroplacental blood flow9 and maternal anemia 
(which is itself due to malaria).10, 11 Febrile malaria episodes which are more 
likely among women with low immunity are thought to induce uterine 
contractions which are mediated by elevated levels of TNF-alpha leading to 
preterm birth.12, 13 Malaria is also associated with hypertensive disorders of 
pregnancy such as gestational hypertension and preeclampsia in young 
primigravid women 14-16 and these are risk factors for LBW.17 Low birth weight 
children have an increased incidence of hypertension in later life.18-21 In a 
study conducted in Ibadan, Nigeria, infants of mothers who experienced 
malaria during pregnancy had a higher increase in BP levels during the first 
year of life compared to those who did not.22 Because BP levels track strongly 
through to adulthood, such differences could significantly influence the 
prevalence of adult hypertension.23-25 By virtue of its association with 
hypertensive disorders of pregnancy that are themselves risk factors for 
essential hypertension in women26, 27, malaria likely contributes to an inter-
generational vicious cycle of disease susceptibility as hypertensive parents 
bear children who develop hypertension more frequently.28, 29  
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(2) Malaria is associated with stunting and malnutrition in childhood30, 31 which 
predisposes to the development of hypertension in later life.19, 23, 32 
Although the biological pathways have not been fully characterized, 
postulated mechanisms involved in the development of hypertension following 
stunting and chronic malnutrition include reduced nephron numbers18 and 
premature senescence in the kidney which is particularly prominent when 
there is rapid weight gain after growth restriction.33 In addition, Jamaican 
survivors of severe acute malnutrition in childhood were found at age 30 
years to have markedly smaller left ventricular outflow tracts with reduced 
cardiac output in the presence of elevated peripheral resistance, a pattern of 
changes that is likely to lead to hypertension in later life.34  
(3) Malaria is a cause of chronic inflammation35 and inflammation predisposes 
to cardiovascular diseases in high-income countries.36 In a prospective study 
of 20525 female US health professionals, there was a linear relationship 
between baseline C-reactive protein levels and incident hypertension.37 
Patients with inflammatory bowel disease and rheumatoid arthritis have 
increased arterial stiffness, which precedes hypertension.38-40 The link 
between inflammatory conditions and hypertension may be related to 
perturbations in the levels of endothelial-based growth factors. Angiopoietin-2 
(Ang-2) is a multimeric ligand of the Tie 2 receptor, part of a vascular specific 
tyrosine kinase signaling pathway that is essential for vessel development 
and stability.41 Ang-2 is predominantly secreted by endothelial cells and some 
smooth muscle cells in many inflammatory and angiogenic states. Ang-2 
levels are elevated in children with severe malaria in several different 
settings35, 42-45 and in returning travellers infected with malaria46. Ang-2 levels 
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predict cardiovascular disease in children with chronic kidney disease.47 
Although no causal association has been established, several studies have 
demonstrated an association between Ang-2 levels and arterial stiffness and 
BP in adults.48, 49 
Testing the hypothesis 
Observational studies 
Ecological studies examining BP levels in relation to malaria incidence are 
hampered by the lack of finely scaled data on the relevant BP distributions. A 
worldwide study on BP levels had scarce raw data on BP from sSA where 
most malaria endemic countries are situated.1 In contrast there are good 
epidemiological data on the spatial and temporal distribution of malaria.50  
Although traditional case-control studies (with malaria as the exposure and 
hypertension as the outcome) could provide an efficient way to test the 
hypothesis, they are limited by the non-specificity and non-durability of 
immunological markers for malaria, a prerequisite for identifying individuals 
who have previously been exposed to malaria.51-53 This limitation also applies 
to the potential use of propensity scores 54 to assemble groups that are 
comparable in their risk of malaria: in order to generate such scores reliable 
long term measures of malaria would be needed. 
A life-course epidemiological approach with longitudinal cohorts from the 
antenatal period or birth would allow the study of many of the postulated 
pathways through which malaria could be leading to hypertension in LMIC. 
Studies of pregnant women and children exposed to malaria in demographic 
surveillance systems with good quality ascertainment of exposure status are 
necessary. However most demographic surveillance systems in LMIC were 
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only set up in the last 15 years, and therefore may not have accumulated 
enough follow-up time to examine these outcomes, assuming that the biases 
of such retrospective studies can be overcome. Prospective surveillance on 
the other hand would also require long follow-up and be expensive to 
conduct.  
Randomized intervention studies  
Because malaria is of such great public interest, there have been and will 
continue to be a succession of randomized controlled trials of interventions 
tested at population level such as vaccines, bed nets and drug treatments. 
For those interventions that turn out to be effective it might be possible to 
examine their effect on arterial stiffness and blood pressure. Prospective 
studies of interventions known to be effective as well as studies of controlled 
human malaria infection55 can not be used here because although they satisfy 
the criterion of having 2 randomized groups with and without malaria, the fact 
that the vascular outcomes being tested are potentially irreversible pose an 
ethical challenge.56 As with observational studies, extended follow up might 
be needed as vascular differences in trial groups due to the effects of malaria 
may take longer to be apparent compared to the anti-malarial effects of the 
interventions. 
Animal studies are hampered by the fact that murine models of malaria and 
hypertension are imperfect approximations of their human analogues that 
have complex pathophysiology. 57, 58 
Genetic studies 
Mendelian randomization (MR) studies, where genetic polymorphisms are 
used as instrumental variables representing malaria exposure, would be 
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particularly attractive for answering the question as they overcome many of 
the limitations of observational and intervention studies described above. 59 
Several hemoglobin polymorphisms provide some level of protection against 
malaria including Hemoglobin C and S, and thalassemia.60-62 A comparison of 
arterial stiffness indices and BP in subjects with and without the 
polymorphisms in regions where they have been exposed to malaria in 
childhood would provide a robust test of the effect of malaria exposure on the 
development of hypertension.  
An important prerequisite for using MR to make causal inferences regarding 
the effects of environmental exposures, is that the polymorphisms should not 
display pleiotropic effects, i.e. they should not influence the outcome being 
studied through a pathway that is independent of the environmental exposure 
that they are being used as a proxy for.59 Some studies suggest that 
individuals with the sickle cell trait (SCT) are more likely to suffer from 
cardiovascular events especially under extreme conditions such as military 
training or athletics.63, 64 A recent study among African Americans found 
similar baseline BP in those with and without SCT although on follow up there 
was an increased incidence of chronic kidney disease in individuals with 
SCT.65 To exclude the possibility of confounding by pleiotropy, it may be 
necessary to include a control group that has not been exposed to malaria or 
use additional independent genetic polymorphisms, such as alpha 
thalassemia. If malaria causes hypertension and there are no pleiotropic 
effects of SCT, then one would expect to find higher BP in individuals without 
SCT compared to those with SCT in groups that have been exposed to 
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malaria. Conversely there would be no difference in BP based on trait status 
among those who have not been exposed to malaria. 
 Implications of the hypothesis 
Current efforts at understanding hypertension in LMIC have had a narrow 
focus anchored on traditional risk factors identified among populations in high-
income countries. Confirmation of the causative role of malaria in elevating 
BP would be of immense scientific interest and could lead to a paradigm shift 
on how to control hypertension in LMIC.  
Malaria is only one of many infectious diseases that have a high incidence 
across LMICs. The inflammatory pathways activated in malaria infection are 
similar to those of other illnesses.66 It is therefore likely that if malaria 
contributes to the burden of hypertension through inflammation, the same 
could be true of other chronic infections such as HIV and tuberculosis, 
providing a novel impetus for the study and control of these infections. 
Currently most treatment for infectious illnesses is focused on eliminating the 
pathogen with little regard for modulating the inflammatory responses that 
might result in adverse vascular consequences later. Elucidating these 
inflammatory pathways and their consequences would pave the way for trials 
of adjunctive therapy such as statins or specific cytokine antagonists to 
prevent adverse vascular remodeling as a result of infection. 
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Novelty and Significance 
What is known? 
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Malaria and high blood pressure are widespread in low and middle-income 
countries. 
Malaria is known to cause low birth weight, stunting and inflammation. 
Low birth weight, stunting and inflammation are associated with the 
development of arterial stiffness and high blood pressure in developed 
countries. 
What new information does this article contribute? 
In this article we review the literature in support of the hypothesis that malaria 
could be contributing to the widespread problem of hypertension in low and 
middle-income countries. We also outline several ways in which this 
hypothesis could be proven or refuted. If proven, this link would be a 
paradigm shift in efforts to prevent and control high blood pressure in low and 
middle-income countries. 
